Breaking News Instant updates and real-time market news.

DNPUF

Sumitomo Dainippon

$19.75 /

+ (+0.00%)

16:04
06/14/21
06/14
16:04
06/14/21
16:04

Sumitomo Dainippon downgraded to Hold from Buy at Jefferies

Jefferies analyst Stephen Barker downgraded Sumitomo Dainippon to Hold from Buy with a 2,400 yen price target.

TODAY'S FREE FLY STORIES

Earnings
Hanesbrands sees Q3 adjusted EPS 45c-48c, consensus 41c » 06:01
08/05/21
08/05
06:01
08/05/21
06:01
HBI

Hanesbrands

$18.36 /

-0.32 (-1.71%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wells Fargo
Wells Fargo upgrades Hanesbrands on share gains, Champion growth
07/13/21 Wells Fargo
Hanesbrands upgraded to Overweight from Equal Weight at Wells Fargo
05/12/21
Fly Intel: Top five analyst upgrades
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

Initiation
Coinbase initiated with a Buy at Redburn » 06:01
08/05/21
08/05
06:01
08/05/21
06:01
COIN

Coinbase

$244.30 /

+14.23 (+6.19%)

Redburn analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIN Coinbase
$244.30 /

+14.23 (+6.19%)

COIN Coinbase
$244.30 /

+14.23 (+6.19%)

07/30/21 Mizuho
Coinbase price target lowered to $210 from $225 at Mizuho
07/07/21 Oppenheimer
Coinbase price target raised to $444 from $434 at Oppenheimer
07/01/21 Mizuho
Coinbase Q2 sales beat may come with 'killjoy,' says Mizuho
06/16/21
Fly Intel: Top five analyst initiations
COIN Coinbase
$244.30 /

+14.23 (+6.19%)

  • 14
    Apr
COIN Coinbase
$244.30 /

+14.23 (+6.19%)

COIN Coinbase
$244.30 /

+14.23 (+6.19%)

COIN Coinbase
$244.30 /

+14.23 (+6.19%)

Earnings
Hanesbrands reports Q2 adjusted EPS 47c, consensus 39c » 06:00
08/05/21
08/05
06:00
08/05/21
06:00
HBI

Hanesbrands

$18.36 /

-0.32 (-1.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wells Fargo
Wells Fargo upgrades Hanesbrands on share gains, Champion growth
07/13/21 Wells Fargo
Hanesbrands upgraded to Overweight from Equal Weight at Wells Fargo
05/12/21
Fly Intel: Top five analyst upgrades
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

Downgrade
Nevro downgraded to Neutral from Buy at Citi » 06:00
08/05/21
08/05
06:00
08/05/21
06:00
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

05:57 Today Citi
Nevro downgraded to Neutral from Buy at Citi
04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
04:39 Today William Blair
Nevro downgraded to Market Perform from Outperform at William Blair
07/19/21 Piper Sandler
Nevro FDA approval of PDN adds key growth driver, says Piper Sandler
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Initiation
Owlet initiated with a Neutral at Citi » 05:59
08/05/21
08/05
05:59
08/05/21
05:59
OWLT

Owlet

$9.04 /

-0.46 (-4.84%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OWLT Owlet
$9.04 /

-0.46 (-4.84%)

07/26/21 Cowen
Owlet initiated with an Outperform at Cowen
Upgrade
Wynn Resorts upgraded to Buy from Neutral at Citi » 05:58
08/05/21
08/05
05:58
08/05/21
05:58
WYNN

Wynn Resorts

$90.96 /

-4.11 (-4.32%)

Citi analyst George Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

07/28/21 Goldman Sachs
Wynn Resorts price target lowered to $110 from $116 at Goldman Sachs
05/11/21 Morgan Stanley
Wynn Resorts price target raised to $145 from $140 at Morgan Stanley
05/11/21 Citi
Citi upgrades Wynn Resorts to Neutral on 'value-enhancing' deal
05/11/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

  • 09
    Feb
WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

Upgrade
e.l.f. Beauty upgraded to Buy from Neutral at Citi » 05:57
08/05/21
08/05
05:57
08/05/21
05:57
ELF

e.l.f. Beauty

$28.00 /

-0.6 (-2.10%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

07/14/21
Fly Intel: Top five analyst initiations
07/14/21 Raymond James
e.l.f. Beauty initiated with an Outperform at Raymond James
07/13/21 Raymond James
e.l.f. Beauty initiated with an Outperform at Raymond James
05/27/21 Truist
e.l.f. Beauty price target raised to $35 from $30 at Truist
ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

Upgrade
Walmart upgraded to Overweight after share underperformance at Wells Fargo » 05:57
08/05/21
08/05
05:57
08/05/21
05:57
WMT

Walmart

$142.86 /

-0.97 (-0.67%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

05:27 Today Wells Fargo
Walmart upgraded to Overweight from Equal Weight at Wells Fargo
07/12/21 Morgan Stanley
Walmart+ membership 'treading water' in 9M-10M range, says Morgan Stanley
07/08/21 Craig-Hallum
Craig-Hallum bullish on Revolution Acceleration Acquisition, initiates with Buy
06/24/21 BofA
Comcast not pressured to make any imminent acquisition, says BofA
WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

Downgrade
Nevro downgraded to Neutral from Buy at Citi » 05:57
08/05/21
08/05
05:57
08/05/21
05:57
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
04:39 Today William Blair
Nevro downgraded to Market Perform from Outperform at William Blair
07/19/21 Piper Sandler
Nevro FDA approval of PDN adds key growth driver, says Piper Sandler
07/09/21 Redburn
Nevro downgraded to Neutral from Buy at Redburn
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Downgrade
Inogen downgraded to Sector Weight on lower visibility at KeyBanc » 05:54
08/05/21
08/05
05:54
08/05/21
05:54
INGN

Inogen

$82.28 /

+4.4 (+5.65%)

KeyBanc analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INGN Inogen
$82.28 /

+4.4 (+5.65%)

INGN Inogen
$82.28 /

+4.4 (+5.65%)

04:43 Today KeyBanc
Inogen downgraded to Sector Weight from Overweight at KeyBanc
06/04/21 William Blair
William Blair upgrades Inogen on 'needed refresh' to strategy
06/04/21 William Blair
Inogen upgraded to Outperform from Market Perform at William Blair
05/05/21 KeyBanc
Inogen price target raised to $75 from $60 at KeyBanc
INGN Inogen
$82.28 /

+4.4 (+5.65%)

Downgrade
Revolve Group downgraded to Sector Weight post results at KeyBanc » 05:52
08/05/21
08/05
05:52
08/05/21
05:52
RVLV

Revolve Group

$71.30 /

-2.14 (-2.91%)

KeyBanc analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

04:45 Today Raymond James
Revolve Group downgraded to Outperform from Strong Buy at Raymond James
04:44 Today KeyBanc
Revolve Group downgraded to Sector Weight from Overweight at KeyBanc
08/02/21 MKM Partners
Revolve Group price target raised to $80 from $60 at MKM Partners
06/29/21 B. Riley
Revolve Group price target raised to $80 from $58 at B. Riley
RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

  • 18
    Nov
  • 11
    Sep
RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

Initiation
Smith Micro initiated with a Buy at Dawson James » 05:50
08/05/21
08/05
05:50
08/05/21
05:50
SMSI

Smith Micro

$5.02 /

-0.17 (-3.28%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

04/27/21 Benchmark
Smith Micro initiated with a Buy at Benchmark
04/20/21 B. Riley
Smith Micro price target raised to $9.50 from $8 at B. Riley
03/15/21 Lake Street
Smith Micro price target raised to $9 from $7 at Lake Street
01/13/21 B. Riley Securities
Smith Micro price target raised to $8 from $5.50 at B. Riley Securities
SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

  • 11
    Mar
SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

Initiation
Oblong initiated with a Buy at Dawson James » 05:49
08/05/21
08/05
05:49
08/05/21
05:49
OBLG

Oblong

$2.63 /

+0.055 (+2.14%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OBLG Oblong
$2.63 /

+0.055 (+2.14%)

04/27/21 Dawson James
Oblong initiated with a Buy at Dawson James
OBLG Oblong
$2.63 /

+0.055 (+2.14%)

Initiation
Crown Electrokinetics initiated with a Buy at Dawson James » 05:49
08/05/21
08/05
05:49
08/05/21
05:49
CRKN

Crown Electrokinetics

$3.33 /

-0.135 (-3.90%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRKN Crown Electrokinetics
$3.33 /

-0.135 (-3.90%)

CRKN Crown Electrokinetics
$3.33 /

-0.135 (-3.90%)

03/09/21 Colliers
Crown Electrokinetics initiated with a Buy at Colliers
03/01/21 Roth Capital
Crown Electrokinetics initiated with a Buy at Roth Capital
  • 26
    Jan
Hot Stocks
Hookipa Pharma publishes pre-clinical data on LCMV immunotherapeutic » 05:42
08/05/21
08/05
05:42
08/05/21
05:42
HOOK

Hookipa Pharma

$7.43 /

-0.01 (-0.13%)

Hookipa Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HOOK Hookipa Pharma
$7.43 /

-0.01 (-0.13%)

HOOK Hookipa Pharma
$7.43 /

-0.01 (-0.13%)

04/08/21 Morgan Stanley
Hookipa Pharma initiated with an Overweight at Morgan Stanley
11/30/20 JMP Securities
Hookipa Pharma price target raised to $25 from $19 at JMP Securities
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Truist
Hookipa Pharma initiated with a Buy at Truist
HOOK Hookipa Pharma
$7.43 /

-0.01 (-0.13%)

  • 09
    Dec
Upgrade
CapitaLand Integrated Commercial upgraded to Buy from Neutral at Goldman Sachs » 05:42
08/05/21
08/05
05:42
08/05/21
05:42
CPAMF

CapitaLand Integrated Commercial

$1.53 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPAMF CapitaLand Integrated Commercial
$1.53 /

+ (+0.00%)

03/23/21 Goldman Sachs
CapitaLand Integrated Commercial initiated with a Neutral at Goldman Sachs
Earnings
Nevro withdraws 2021 guidance due to Covid uncertainties » 05:40
08/05/21
08/05
05:40
08/05/21
05:40
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

The company said in last…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
04:39 Today William Blair
Nevro downgraded to Market Perform from Outperform at William Blair
07/19/21 Piper Sandler
Nevro FDA approval of PDN adds key growth driver, says Piper Sandler
07/09/21 Redburn
Nevro downgraded to Neutral from Buy at Redburn
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Earnings
Nice raises FY21 EPS view to $6.26-$6.46 from $6.19-$6.39, consensus $6.29 » 05:39
08/05/21
08/05
05:39
08/05/21
05:39
NICE

Nice

$277.53 /

+2.13 (+0.77%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

07/19/21 Jefferies
Jefferies says Zoom deal could drive short-term weakness in RingCentral and Nice
07/06/21 RBC Capital
Nice upgraded to Outperform on cloud platform growth at RBC
07/06/21 RBC Capital
Nice upgraded to Outperform from Sector Perform at RBC Capital
06/09/21
Fly Intel: Top five analyst upgrades
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

Earnings
Nice sees Q3 EPS $1.51-$1.61, consensus $1.56 » 05:37
08/05/21
08/05
05:37
08/05/21
05:37
NICE

Nice

$277.53 /

+2.13 (+0.77%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

07/19/21 Jefferies
Jefferies says Zoom deal could drive short-term weakness in RingCentral and Nice
07/06/21 RBC Capital
Nice upgraded to Outperform on cloud platform growth at RBC
07/06/21 RBC Capital
Nice upgraded to Outperform from Sector Perform at RBC Capital
06/09/21
Fly Intel: Top five analyst upgrades
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

Earnings
Nice reports Q2 EPS $1.57, consensus $1.51 » 05:36
08/05/21
08/05
05:36
08/05/21
05:36
NICE

Nice

$277.53 /

+2.13 (+0.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

07/19/21 Jefferies
Jefferies says Zoom deal could drive short-term weakness in RingCentral and Nice
07/06/21 RBC Capital
Nice upgraded to Outperform on cloud platform growth at RBC
07/06/21 RBC Capital
Nice upgraded to Outperform from Sector Perform at RBC Capital
06/09/21
Fly Intel: Top five analyst upgrades
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

Upgrade
Halliburton upgraded to Hold from Reduce at HSBC » 05:35
08/05/21
08/05
05:35
08/05/21
05:35
HAL

Halliburton

$19.20 /

-1.165 (-5.72%)

HSBC analyst Abhishek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAL Halliburton
$19.20 /

-1.165 (-5.72%)

HAL Halliburton
$19.20 /

-1.165 (-5.72%)

08/02/21 Goldman Sachs
Liberty Oilfield Services downgraded to Neutral from Buy at Goldman Sachs
07/21/21
Fly Intel: Top five analyst upgrades
07/21/21 Exane BNP Paribas
Halliburton upgraded to Neutral from Underperform at Exane BNP Paribas
07/21/21 Barclays
Halliburton price target raised to $30 from $29 at Barclays
HAL Halliburton
$19.20 /

-1.165 (-5.72%)

HAL Halliburton
$19.20 /

-1.165 (-5.72%)

HAL Halliburton
$19.20 /

-1.165 (-5.72%)

HAL Halliburton
$19.20 /

-1.165 (-5.72%)

Hot Stocks
Passage Bio announces passing of chairman Tadataka Yamada » 05:34
08/05/21
08/05
05:34
08/05/21
05:34
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

Passage Bio announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
New Fortress Energy reports Q2 EPS (3c), consensus 16c » 05:31
08/05/21
08/05
05:31
08/05/21
05:31
NFE

New Fortress Energy

$30.31 /

-0.43 (-1.40%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFE New Fortress Energy
$30.31 /

-0.43 (-1.40%)

NFE New Fortress Energy
$30.31 /

-0.43 (-1.40%)

07/22/21 Barclays
New Fortress Energy price target lowered to $38 from $45 at Barclays
05/13/21 Morgan Stanley
New Fortress Energy resumed with an Overweight at Morgan Stanley
03/16/21 Stifel
New Fortress Energy upgraded to Buy from Hold at Stifel
01/26/21 Credit Suisse
New Fortress Energy price target raised to $50 from $37 at Credit Suisse
NFE New Fortress Energy
$30.31 /

-0.43 (-1.40%)

  • 16
    Dec
NFE New Fortress Energy
$30.31 /

-0.43 (-1.40%)

Recommendations
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer » 05:29
08/05/21
08/05
05:29
08/05/21
05:29
ALLO

Allogene Therapeutics

$22.13 /

+0.23 (+1.05%)

Oppenheimer analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
05/20/21 Jefferies
Allogene update exceeds expectation 'on all fronts,' says Jefferies
05/20/21 Stifel
Allogene data 'better than they appear on the surface,' says Stifel
05/20/21 Truist
Allogene Therapeutics upgraded to Buy from Hold at Truist
ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

ALLO Allogene Therapeutics
$22.13 /

+0.23 (+1.05%)

Earnings
Fiverr cuts FY21 revenue view to $280M-$288M from $302M-$308M » 05:28
08/05/21
08/05
05:28
08/05/21
05:28
FVRR

Fiverr

$230.14 /

+0.26 (+0.11%)

Consensus $307.78M. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$230.14 /

+0.26 (+0.11%)

FVRR Fiverr
$230.14 /

+0.26 (+0.11%)

05/26/21 RBC Capital
Fiverr initiated with an Outperform at RBC Capital
05/10/21 Citi
Fiverr price target lowered to $280 from $350 at Citi
04/26/21 Needham
Fiverr initiated with a Buy at Needham
04/26/21 Needham
Fiverr initiated with a Buy at Needham
FVRR Fiverr
$230.14 /

+0.26 (+0.11%)

  • 04
    Mar
FVRR Fiverr
$230.14 /

+0.26 (+0.11%)

FVRR Fiverr
$230.14 /

+0.26 (+0.11%)

FVRR Fiverr
$230.14 /

+0.26 (+0.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.